参考文献/References:
[1] GBD 2019 Risk Factors Collaborators. Global burden of 87 risk factors in 204 countries and territories,1990-2019:a systematic analysis for the Global Burden of Disease Study 2019[J]. Lancet (London,England),2020,396(10258):1223-1249.
[2] Calleja-Conde J,Echeverry-Alzate V,Bühler KM,et al. The immune system through the lens of alcohol intake and gut microbiota[J]. Int J Mol Sci,2021,22(14):7485.
[3] Mutlu EA,Gillevet PM,Rangwala H,et al. Colonic microbiome is altered in alcoholism[J]. Am J Physiol Gastrointest Liver Physiol,2012,302(9):G966-G978.
[4] Ferranti EP,Dunbar SB,Dunlop AL,et al. 20 things you didn’t know about the human gut microbiome[J]. J Cardiovasc Nurs,2014,29(6):479-481.
[5] Schroeder BO,B?ckhed F. Signals from the gut microbiota to distant organs in physiology and disease[J]. Nat Med,2016,22(10):1079-1089.
[6] Dixit K,Chaudhari D,Dhotre D,et al. Restoration of dysbiotic human gut microbiome for homeostasis[J]. Life Sci,2021,278:119622.
[7] Beam A,Clinger E,Hao L,et al. Effect of diet and dietary components on the composition of the gut microbiota[J]. Nutrients,2021,13(8):2795.
[8] Malaguarnera G,Giordano M,Nunnari G,et al. Gut microbiota in alcoholic liver disease:pathogenetic role and therapeutic perspectives[J]. ?World J Gastroenterol,2014,20(44):16639-16648.
[9] Bluemel S,Wang L,Kuelbs C,et al. Intestinal and hepatic microbiota changes associated with chronic ethanol administration in mice[J]. Gut Microbes,2020,11(3):265-275.
[10] Wang G,Liu Q,Guo L,et al. Gut microbiota and relevant metabolites analysis in alcohol dependent mice[J]. Front Microbiol,2018,9:1874.
[11] Canesso MCC,Lacerda NL,Ferreira CM,et al. Comparing the effects of acute alcohol consumption in germ-free and conventional mice:the role of the gut microbiota[J]. BMC Microbiol,2014,14:240.
[12] Bj?rkhaug ST,Aanes H,Neupane SP,et al. Characterization of gut microbiota composition and functions in patients with chronic alcohol overconsumption[J]. Gut Microbes,2019,10(6):663-675.
[13] Dubinkina VB,Tyakht AV,Odintsova VY,et al. Links of gut microbiota composition with alcohol dependence syndrome and alcoholic liver disease[J]. Microbiome,2017,5(1):141.
[14] Litwinowicz K,Choroszy M,Waszczuk E,et al. Changes in the composition of the human intestinal microbiome in alcohol use disorder:a systematic review[J]. Am J Drug Alcohol Abuse,2020,46(1):4-12.
[15] Grander C,Adolph TE,Wieser V,et al. Recovery of ethanol-induced depletion ameliorates alcoholic liver disease[J]. Gut,2018,67(5):891-901.
[16] Gu Z,Wu Y,Wang Y,et al. Granules dose-dependently balance intestinal microbiome disorders and ameliorate chronic alcohol-induced liver injury[J]. J Med Food,2020,23(2):114-124.
[17] Yang X,He F,Zhang Y,et al. Inulin ameliorates alcoholic liver disease via suppressing LPS-TLR4-Mψ axis and modulating gut microbiota in mice[J]. Alcohol Clin Exp Res,2019,43(3):411-424.
[18] Bull-Otterson L,Feng W,Kirpich I,et al. Metagenomic analyses of alcohol induced pathogenic alterations in the intestinal microbiome and the effect of Lactobacillus rhamnosus GG treatment[J]. PloS One,2013,8(1):e53028.
[19] Ridlon JM,Kang DJ,Hylemon PB,et al. Gut microbiota,cirrhosis,and alcohol regulate bile acid metabolism in the gut[J]. Dig Dis,2015,33(3):338-345.
[20] Iyer N,Vaishnava S. Alcohol lowers your (intestinal) inhibitions[J]. Cell Host Microbe,2016,19(2):131-133.
[21] Forsyth CB,Farhadi A,Jakate SM,et al. Lactobacillus GG treatment ameliorates alcohol-induced intestinal oxidative stress,gut leakiness,and liver injury in a rat model of alcoholic steatohepatitis[J]. Alcohol,2009,43(2):163-172.
[22] Ferrier L,Bérard F,Debrauwer L,et al. Impairment of the intestinal barrier by ethanol involves enteric microflora and mast cell activation in rodents[J]. Am J Pathol,2006,168(4):1148-1154.
[23] Parlesak A,Sch?fer C,Schütz T,et al. Increased intestinal permeability to macromolecules and endotoxemia in patients with chronic alcohol abuse in different stages of alcohol-induced liver disease[J]. J Hepatol,2000,32(5):742-747.
[24] Grewal RK,Mahmood A. Ethanol induced changes in glycosylation of mucins in rat intestine[J]. Ann Gastroenterol,2009,22(3):178-183.
[25] Tripathi A,Debelius J,Brenner DA,et al. The gut–liver axis and the intersection with the microbiome[J]. Nat Rev Gastroenterol Hepatol,2018,15(7):397-411.
[26] Vassallo G,Mirijello A,Ferrulli A,et al. Review article:alcohol and gut microbiota —The possible role of gut microbiota modulation in the treatment of alcoholic liver disease[J]. Aliment Pharmacol Ther,2015,41(10):917-927.
[27] Bala S,Marcos M,Kodys K,et al. Up-regulation of microRNA-155 in macrophages contributes to increased tumor necrosis factor α(TNFα) production via increased mRNA half-life in alcoholic liver disease [J]. J Biol Chem,2011,286(2):1436-1444.
[28] Hritz I,Mandrekar P,Velayudham A,et al. The critical role of toll-like receptor (TLR) 4 in alcoholic liver disease is independent of the common TLR adapter MyD88[J]. Hepatology,2008,48(4):1224-1231.
[29] Bajaj JS,Hylemon PB. Gut-liver axis alterations in alcoholic liver disease:are bile acids the answer?[J]. Hepatology,2018,67(6):2074-2075.
[30] Hsiao EY,McBride SW,Hsien S,et al. Microbiota modulate behavioral and physiological abnormalities associated with neurodevelopmental disorders[J]. Cell,2013,155(7):1451-1463.
[31] Leclercq S,Cani PD,Neyrinck AM,et al. Role of intestinal permeability and inflammation in the biological and behavioral control of alcohol-dependent subjects[J]. Brain Behav Immun,2012,26(6):911-918.
[32] Leclercq S,de Timary P,Delzenne NM,et al. The link between inflammation,bugs,the intestine and the brain in alcohol dependence[J]. Transl Psychiatry,2017,7(2):e1048.
[33] Mendes BG,Schnabl B. From intestinal dysbiosis to alcohol-associated liver disease[J]. Clin Mol Hepatol,2020,26(4):595-605.
[34] Philips CA,Pande A,Shasthry SM,et al. Healthy donor fecal microbiota transplantation in steroid-ineligible severe alcoholic hepatitis:a pilot study[J]. Clin Gastroenterol Hepatol,2017,15(4):600-602.
[35] Bajaj JS,Gavis EA,Fagan A,et al. A randomized clinical trial of fecal microbiota transplant for alcohol use disorder[J]. Hepatology,2021,73(5):1688-1700.
[36] Salminen S,Collado MC,Endo A,et al. The International Scientific Association of Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of postbiotics[J]. Nat Rev Gastroenterol Hepatol,2021,18(9):649-667.
[37] Hendrikx T,Duan Y,Wang Y,et al. Bacteria engineered to produce IL-22 in intestine induce expression of REG3G to reduce ethanol-induced liver disease in mice[J]. Gut,2019,68(8):1504-1515.
相似文献/References:
[1]杨娟,综述,王佑华,等.肠道菌群与血管内炎症[J].心血管病学进展,2016,(3):263.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.012]
YANG Juan,WANG Youhua,YUAN Suyun.Relationship Between Gut Microbiota and Vascular Inflammation[J].Advances in Cardiovascular Diseases,2016,(2):263.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.012]
[2]张琪 宋晓鹏 任茂佳 吴广 赵兴胜.氧化三甲胺与心血管疾病的研究新进展[J].心血管病学进展,2020,(1):81.[doi:10.16806/j.cnki.issn.1004-3934.2020.01.022]
ZHANG Qi,SONG Xiaopeng,REN Maojia,et al.Trimethylamine Oxide and Cardiovascular Diseases[J].Advances in Cardiovascular Diseases,2020,(2):81.[doi:10.16806/j.cnki.issn.1004-3934.2020.01.022]
[3]李靖,任彭,努尔比耶·买买提,等.三甲胺-N-氧化物与冠心病和心力衰竭的研究进展[J].心血管病学进展,2020,(3):272.[doi:10.16806/j.cnki.issn.1004-3934.2019.00.014]
LI Jing,REN Peng,Nuerbiye·Maimaiti,et al.Trimethylamine-N-oxide and Coronary Heart Disease and Heart Failure[J].Advances in Cardiovascular Diseases,2020,(2):272.[doi:10.16806/j.cnki.issn.1004-3934.2019.00.014]
[4]王猛 江洪.肠道菌群及其代谢产物与心房颤动的研究进展[J].心血管病学进展,2022,(3):214.[doi:10.16806/j.cnki.issn.1004-3934.2022.03.000]
WANG Meng,JIANG Hong.Gut Microbiota an d Its Metabolites in Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2022,(2):214.[doi:10.16806/j.cnki.issn.1004-3934.2022.03.000]
[5].肠-脑轴与心血管疾病的研究进展[J].心血管病学进展,2022,(7):595.[doi:10.16806/j.cnki.issn.1004-3934.2022.07.000]
TAN Wuping,W ANG Meng,ZHOU Xiaoya.Gut-Brain Axis and Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2022,(2):595.[doi:10.16806/j.cnki.issn.1004-3934.2022.07.000]
[6]刘杏利 高中山 段豪亮 赵奕 马玉兰.肠道菌群及其代谢物与心律失常关系的研究进展[J].心血管病学进展,2022,(11):1002.[doi:10.16806/j.cnki.issn.1004-3934.2022.11.009]
LIU Xingli,GAO Zhongshan,DUAN Haoliang,et al.The Relationship Between Intestinal Flora and Its Metabolites and Arrhythmia[J].Advances in Cardiovascular Diseases,2022,(2):1002.[doi:10.16806/j.cnki.issn.1004-3934.2022.11.009]
[7]张嘉原 张莉.果糖代谢与血脂异常的研究进展[J].心血管病学进展,2022,(12):1114.[doi:10.16806/j.cnki.issn.1004-3934.2022.12.013]
ZHANG Jiayuan ZHANG Li.Fructose Metabolism and DyslipidemiaA Systematic Review[J].Advances in Cardiovascular Diseases,2022,(2):1114.[doi:10.16806/j.cnki.issn.1004-3934.2022.12.013]
[8]卢燕 刘亚萍 罗强 张全波 汪汉.肠道菌群及其代谢物与痛风[J].心血管病学进展,2023,(2):177.[doi:10.16806/j.cnki.issn.1004-3934.2023.02.018]
LU Yan,LIU Yaping,LUO Qiang,et al.Intestinal Flora and Its Metabolites and Gout[J].Advances in Cardiovascular Diseases,2023,(2):177.[doi:10.16806/j.cnki.issn.1004-3934.2023.02.018]
[9]蒋振江 刘富强 王军奎.肠道菌群与肥胖的关系研究进展[J].心血管病学进展,2023,(3):265.[doi:10.16806/j.cnki.issn.1004-3934.2023.03.017]
JIANG Zhenjiang,LIU Fuqiang,WANG Junkui.The Relationship Between Gut Microbiota and Obesity[J].Advances in Cardiovascular Diseases,2023,(2):265.[doi:10.16806/j.cnki.issn.1004-3934.2023.03.017]
[10]黄露霈 成泽东.肠道微生物细胞外囊泡对心血管系统影响的研究进展[J].心血管病学进展,2023,(4):355.[doi:10.16806/j.cnki.issn.1004-3934.2023.04.015]
UANG Lupei,CHENG Zedong ?/html>.Research Progress on the Effect of Intestinal Microbial?#160Extracellular Vesicles on Cardiovascular System[J].Advances in Cardiovascular Diseases,2023,(2):355.[doi:10.16806/j.cnki.issn.1004-3934.2023.04.015]